Matinas BioPharma Holdings, Inc. (MTNB) Stock Price, Quote & AI Analysis
Live MTNB stock price, real-time charts, AI-powered analysis, technical analysis, earnings insights, and market sentiment for Matinas BioPharma Holdings, Inc..
TradeVae provides AI-driven analysis and real-time market intelligence for Matinas BioPharma Holdings, Inc. (MTNB), including price action, technical indicators, earnings performance, analyst sentiment, and risk-aware market context.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Matinas BioPharma Holdings, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Matinas BioPharma Holdings, Inc. Overview
Company information
Company Overview
Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.
Company Details
Technical Indicators
Key technical analysis metrics and indicators
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Matinas BioPharma Holdings, Inc. Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...